Despite its impact, UI is underreported by patients, underdetected by clinicians, and undertreated. Embarrassment, a belief among both patients and clinicians that UI is a normal part of aging, and an assumption that not much can be done for UI in older adults are key factors. Community healthcare providers can reduce the impact of UI by informing patients and other clinicians that effective management is attainable.
This issue will present an overview of UI and the recommended, stepwise approach for managing the most common types in older adults. This issue will review the medications used for the treatment of urge UI and overactive bladder (OAB), including 6 antimuscarinicantimuscarinic agents and newer medications such as mirabegron (MyrbetriqTM) and onabotulinumtoxinA (BOTOX®). Medications used in the management of stress UI will also be discussed.
- Pharmacists, Nurse Practitioners, Clinical Nurse Specialists, and Registered Nurses
CE activities for Pharmacists and Pharmacy Technicians:
This continuing education (CE) activity meets the requirements of all state boards of pharmacy for approved continuing education hours. CE credit is automatically reported to CPE Monitor.
The American Nurses Credentialing Center (ANCC) for formally approved continuing education (CE) hours, and CE hours of pharmacotherapeutics.
The American Academy of Nurse Practitioners Certification Program (AANPCP) for acceptable, accredited CE.
- The ANCC requires all advanced practice nursing certificants (CNSs and NPs) to complete 25 CE hours of pharmacotherapeutics as a portion of the required 75 continuing education hours.
- Pharmacology CE is recommended by the AANPCP and will be required for Certificants renewing certification starting January 2017.
- Most State Boards of Nursing require a minimum number of pharmacy contact hours to renew an advanced practice license.
Requirements for CE Credit
- Explain non-drug measures than can minimize the need for or intensity of drug therapy for urinary incontinence (UI).
- Describe the symptoms and prevalence of urge, stress and mixed UI. List 2 myths about UI in older adults.
- Indicate key drug therapies for each type of UI and overactive bladder syndrome.
- Describe the common and serious side effects of antimuscarinic agents. Counsel patients about side effects, including self-management and when to seek prompt medical attention.
Pamela Mausner, MD
Brief Bio : Pamela Mausner, MD; Medical Writer/Editor and Healthcare Advocate; and Associate Editor, The Rx Consultant.
Disclosure : Dr.Mausner reports no financial relationship with the manufacturer(s) or provider(s) of any commercial product(s) or service(s) that appear in this issue.
Thomas E. Lackner, PharmD, CGP, FASCP
Brief Bio : Thomas E. Lackner, PharmD, CGP, FASCP, Director of Pharmacy Services, Univita Health
Disclosure : Dr. Lackner reports no financial or personal relationship with any commercial interest producing, marketing, reselling, or distributing a product or service that appears in this issue.
Tracy Farnen, PharmD
Brief Bio : Tracy Farnen, PharmD; Managing Editor, The Rx Consultant.
Disclosure : Dr. Farnen reports no financial relationship with the manufacturer(s) or provider(s) of any commercial product(s) or service(s) that appear in this issue.